381 related articles for article (PubMed ID: 30360719)
1. Recent Advances in the System Biology-based Target Identification and Drug Discovery.
Yadav BS; Tripathi V
Curr Top Med Chem; 2018; 18(20):1737-1744. PubMed ID: 30360719
[TBL] [Abstract][Full Text] [Related]
2. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.
Xie L; Li J; Xie L; Bourne PE
PLoS Comput Biol; 2009 May; 5(5):e1000387. PubMed ID: 19436720
[TBL] [Abstract][Full Text] [Related]
4. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
[TBL] [Abstract][Full Text] [Related]
5. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
6. Systems biology in drug discovery and development.
Berg EL
Drug Discov Today; 2014 Feb; 19(2):113-25. PubMed ID: 24120892
[TBL] [Abstract][Full Text] [Related]
7. Predicting bioprocess targets of chemical compounds through integration of chemical-genetic and genetic interactions.
Simpkins SW; Nelson J; Deshpande R; Li SC; Piotrowski JS; Wilson EH; Gebre AA; Safizadeh H; Okamoto R; Yoshimura M; Costanzo M; Yashiroda Y; Ohya Y; Osada H; Yoshida M; Boone C; Myers CL
PLoS Comput Biol; 2018 Oct; 14(10):e1006532. PubMed ID: 30376562
[TBL] [Abstract][Full Text] [Related]
8. Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.
Wong YH; Lin CL; Chen TS; Chen CA; Jiang PS; Lai YH; Chu L; Li CW; Chen JJ; Chen BS
BMC Med Genomics; 2015; 8 Suppl 4(Suppl 4):S4. PubMed ID: 26680552
[TBL] [Abstract][Full Text] [Related]
9. Ligand-target prediction by structural network biology using nAnnoLyze.
Martínez-Jiménez F; Marti-Renom MA
PLoS Comput Biol; 2015 Mar; 11(3):e1004157. PubMed ID: 25816344
[TBL] [Abstract][Full Text] [Related]
10. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
[TBL] [Abstract][Full Text] [Related]
11. User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation.
Shaker B; Yu MS; Lee J; Lee Y; Jung C; Na D
J Microbiol; 2020 Mar; 58(3):235-244. PubMed ID: 32108318
[TBL] [Abstract][Full Text] [Related]
12. Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.
Engin HB; Gursoy A; Nussinov R; Keskin O
Curr Pharm Des; 2014; 20(8):1201-7. PubMed ID: 23713773
[TBL] [Abstract][Full Text] [Related]
13. Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study.
Singh N; Freiesleben S; Wolkenhauer O; Shukla Y; Gupta SK
Curr Pharm Des; 2017; 23(32):4773-4793. PubMed ID: 28699531
[TBL] [Abstract][Full Text] [Related]
14. Network based elucidation of drug response: from modulators to targets.
Iorio F; Saez-Rodriguez J; di Bernardo D
BMC Syst Biol; 2013 Dec; 7():139. PubMed ID: 24330611
[TBL] [Abstract][Full Text] [Related]
15. Systems approaches to polypharmacology and drug discovery.
Boran AD; Iyengar R
Curr Opin Drug Discov Devel; 2010 May; 13(3):297-309. PubMed ID: 20443163
[TBL] [Abstract][Full Text] [Related]
16. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
Tan L; Batista J; Bajorath J
Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
[TBL] [Abstract][Full Text] [Related]
17. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
18. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
20. Hot-spot analysis for drug discovery targeting protein-protein interactions.
Rosell M; Fernández-Recio J
Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
